Oscar for Best Actor? | Kalshi | $6.4M Volume | Resolves March 15, 2026

The prediction market says Chalamet at 66¢ is nearly a lock. The precursor trail says be smart and look again.

The Setup

The Best Actor Oscar race looked like a coronation. Timothée Chalamet won the Critics Choice Award on January 4. He won the Golden Globe on January 11. Awards pundits slotted him into their “Will Win” columns and moved on to more interesting categories. The prediction market followed: Chalamet sits at 66¢ on Kalshi, implying a roughly two-in-three chance of winning on March 15.

Then the BAFTAs happened.

On February 22 in London, Robert Aramayo — a 33-year-old British actor best known for The Rings of Power — stunned the room by beating Chalamet, Leonardo DiCaprio, Michael B. Jordan, and Ethan Hawke for Best Actor for his performance as a Tourette syndrome advocate in I Swear. The audience gasped. Aramayo himself looked shellshocked. It was the biggest upset of awards season.

Here’s the wrinkle that matters for bettors: I Swear is not eligible for the Oscars. It didn’t meet the Academy’s theatrical release requirements. That means the BAFTA result can’t directly translate to an Oscar win for the spoiler. But it absolutely disrupted the Chalamet narrative — and narrative is the engine that drives Oscar voting.

Oscar ballots opened February 26 and close March 5. The SAG Actor Awards — voted on by 160,000-plus actors who overlap heavily with the Academy’s acting branch — air March 1 on Netflix. Voters will be filling out their ballots in real time as the final precursor drops.

This is a $6.4 million market. Here’s where the contracts are priced as of Feb. 27, 2026:

Nominee	Film	Price	Implied Prob.
Timothée Chalamet	Marty Supreme	66¢	~66%
Leonardo DiCaprio	One Battle After Another	13¢	~13%
Michael B. Jordan	Sinners	11¢	~11%
Ethan Hawke	Blue Moon	10¢	~10%
Wagner Moura	The Secret Agent	4¢	~4%

The Strategy

The precursor scoreboard is messy — and that’s where the edge lives.

Start with Chalamet. His case is strong but not bulletproof. He won Critics Choice and the Golden Globe for Musical or Comedy, giving him two televised trophies. Gold Derby’s expert consensus puts him at about 80%. But his BAFTA loss introduced a variable that the market hasn’t fully processed. In the last decade, the BAFTA Best Actor winner has matched the Oscar winner all but once. Yes, Aramayo isn’t Oscar-eligible — but the fact that BAFTA voters chose someone else entirely over Chalamet reveals he isn’t locking down rooms the way a true frontrunner usually does by late February.

There’s also the performance itself. Variety’s case-against notes that Chalamet’s character in Marty Supreme is “deeply unlikable” — a real obstacle in a category that historically rewards empathy. He’d be the second-youngest Best Actor winner ever at 30. His campaign has been unusually explicit about wanting the Oscar, which can cut both ways with voters. And there’s a historical headwind at SAG: no actor has ever won back-to-back Actor Awards in the ceremony’s 31-year history. Chalamet won last year for A Complete Unknown. Even the guild’s own precedent works against him.

At 66¢, Chalamet offers a $1 payout — a 52% return. For a frontrunner with a genuine crack in the armor, that’s thin margin.

Now look at Michael B. Jordan at 11¢.

Sinners earned a record-breaking 16 Oscar nominations — the most in Academy history for a single film. That number represents massive branch-by-branch support across the entire Academy, not just actors voting for actors. If Sinners has a big night on March 15, Jordan could ride the wave.

His SAG odds are surging. Post-BAFTA, Jordan climbed 6 percentage points at Gold Derby while Chalamet dropped 8. The BAFTA ceremony also created a bizarre sympathy moment: while Jordan and co-star Delroy Lindo were presenting an award, John Davidson — the real-life Tourette syndrome advocate portrayed in I Swear — involuntarily shouted a racial slur from his seat. BAFTA apologized to Jordan and Lindo. The incident generated enormous social media attention and put Jordan’s grace under pressure on full display, which doesn’t hurt with a voting body of actors who pay attention to how their peers carry themselves.

Jordan is a first-time nominee playing twin brothers in a dual role that demands both physical intensity and emotional range. The “overdue” narrative is potent — he was notably snubbed for Fruitvale Station, Creed, and Black Panther. And Sinners isn’t some niche indie; it’s a Ryan Coogler-directed cultural phenomenon.

The knock: genre bias. Sinners is a vampire horror film, and the Academy has historically undervalued genre performances. Some voters may view the twin-brother doubling as a technical achievement rather than an emotional one. But at 11¢, you’re getting 9-to-1 on a nominee whose film has the most nominations in Oscar history, whose SAG momentum is accelerating, and who has a genuine path if the night breaks his way. If Jordan’s true probability is even 15–18%, this is underpriced.

Leonardo DiCaprio at 13¢ is the trickiest to read. One Battle After Another just won Best Film and Best Director at the BAFTAs (six prizes total), and it’s the clear Best Picture frontrunner. DiCaprio has 13 career nominations and already won once for The Revenant. But his performance is frequently described as part of an ensemble rather than a singular showcase. The film’s strength is its breadth — Sean Penn won Supporting Actor at BAFTA, and DiCaprio’s co-stars are pulling nominations in multiple categories. When a film wins everything around an actor but the actor doesn’t win, it usually means the performance is respected but not dominant. DiCaprio at 13¢ is roughly fair — not overpriced, not a screaming value.

Ethan Hawke at 10¢ looks overpriced. Blue Moon didn’t earn a Best Picture nomination, which severely limits his path. He has no major precursor wins this season. He’s a respected veteran, but respected veterans at 10¢ without institutional support don’t win Best Actor.

Wagner Moura at 4¢ is the purest longshot. He won the Golden Globe for Drama and the Best Actor prize at Cannes — legitimate credentials. But he wasn’t even nominated for the SAG Actor Awards (the guild shut out all foreign-language performances this year). Without a SAG nomination, Moura has no remaining televised platform before Oscar night. At 4¢, this feels roughly fair for a Cannes winner with a Globe — it’s not zero, but the path is extremely narrow.

The Payoff

The trade: Jordan YES at 11¢ is the clearest value on the board.

You’re not betting that Jordan is the likely winner. You’re betting that a 9-to-1 payout underestimates the real probability for a nominee with record-breaking institutional support, accelerating precursor momentum, and a first-nomination narrative that Oscar voters love. Even if you assign him only a 15–20% chance, 11¢ offers positive expected value.

If you want a hedge, pairing Jordan YES (11¢) with Chalamet YES (66¢) costs 77¢ and covers the two most likely winners. One of those contracts pays $1.

The contrarian fade: Hawke NO at 92¢ is a near-certainty for an 8.7% return. No Best Picture nomination, no precursor wins, no path. It’s not exciting, but it’s close to free money.

For those who want to play Chalamet straight, 66¢ isn’t a bad bet — he’s still the most likely winner. But the BAFTA loss, the SAG result pending on March 1, and the thin margin make it a mediocre value bet. You’re paying frontrunner prices for a frontrunner who just took a public hit.

The March 1 SAG ceremony is the last data point before Oscar ballots close on March 5. If Jordan wins SAG — or even makes it close — his Kalshi price will move fast. At 11¢, you’re buying before the final catalyst.

The Oscar airs March 15 at 7 PM ET on ABC. All contracts resolve that night.

Looking to legally bet on politics, entertainment, and more? Prediction markets on Kalshi and Polymarket let you put real money behind your analysis. This article is for informational purposes and does not constitute financial advice.